{"organizations": [], "uuid": "4cc99659f60d83e47432c216edaf8aaf3541896a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-la-jolla-pharmaceutical-says-estab/brief-la-jolla-pharmaceutical-says-established-wholesale-acquisition-cost-of-single-dose-vial-of-giapreza-at-1500-vial-idUSFWN1PP0SE", "country": "US", "domain_rank": 408, "title": "BRIEF-La Jolla Pharmaceutical Says Established Wholesale Acquisition Cost of Single-Dose Vial Of Giapreza At $1,500/ Vial", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.984, "site_type": "news", "published": "2018-01-30T19:22:00.000+02:00", "replies_count": 0, "uuid": "4cc99659f60d83e47432c216edaf8aaf3541896a"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-la-jolla-pharmaceutical-says-estab/brief-la-jolla-pharmaceutical-says-established-wholesale-acquisition-cost-of-single-dose-vial-of-giapreza-at-1500-vial-idUSFWN1PP0SE", "ord_in_thread": 0, "title": "BRIEF-La Jolla Pharmaceutical Says Established Wholesale Acquisition Cost of Single-Dose Vial Of Giapreza At $1,500/ Vial", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "la jolla pharmaceutical co", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 22 AM / Updated 12 minutes ago BRIEF-La Jolla Pharmaceutical Says Established Wholesale Acquisition Cost of Single-Dose Vial Of Giapreza At $1,500/ Vial Reuters Staff 1 Min Read \nJan 30 (Reuters) - La Jolla Pharmaceutical Co: \n* LA JOLLA PHARMACEUTICAL CO - ESTABLISHED WHOLESALE ACQUISITION COST OF $1,500 PER VIAL FOR A 1 ML, SINGLE-DOSE, 2.5 MG/ML VIAL OF GIAPREZA Source text: ( bit.ly/2nm3hfv ) Further company coverage:", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2nm3hfv"], "published": "2018-01-30T19:22:00.000+02:00", "crawled": "2018-01-30T13:38:14.024+02:00", "highlightTitle": ""}